Chemokine Receptor Expression in Oral Squamous Cell Carcinoma: Correlation with Growth Factor- and Cytokinemediated Cell Migration in vitro

Oral Science International

Volumn 4, Issue 2, 2007, Pages 73-85

  Muraoka, Katsumi ^a   Okumura, Kazuhiko ^a   Kitajo, Hiroyuki ^a   Kato, Hidetaka ^a   Arisue, Makoto ^a  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

1L 1 ; Chemokine receptors; INF ; TGF 1; TNF

Indexed keywords

EID: 84939890960     PISSN: 13488643     EISSN: None     Source Type: Journal    
DOI: 10.11277/osi.4.73     Document Type: Article

References (39)

1. Mao L., Hong W.K., and Papadimitrakopoulou V.A.: Focus on head and neck cancer. Cancer Cell 5: 311–316, 2004.
2. Genden E. M., Ferlito A., Bradly P. J., Rinaldo A., and Scully C.: Neck disease and distant metastases. Oral Oncol 39: 207–212, 2003.
3. Rossi D., and Zlotnik A.: The biology of chemokines and their receptors. Annu Rev Immunol 18: 217–242, 2000.
4. Murdoch C., and Finn A.: Chemokine receptors and their role in inflammation and infectious diseases. Blood 95: 3032–3043, 2000.
5. Balkwill F. : Cancer and the chemokine network. Nature Rev Cancer 4: 540–550, 2004.
6. Takahashi K., Kanazawa H., Akiyama Y., Tazaki S., Takahara M., Muto T., Tanzawa T., and Sato K.: Establishment and characterization of a cell line (SAS) from poory differentiated human squamous cell carcinoma of the tongue. J Jpn Stomatol Soc 38: 20–28, 1989.
7. Okumura K., Konishi A., Tanaka M., Kanazawa M., Kogawa K., and Niitsu Y. : Establishment of high- and low-invasion clones derived for a human tongue squamous-cell carcinoma cell line SAS. J Cancer Res Clin Oncol 122: 243–248, 1996.
8. Momose F., Araida T., Negishi A., Ichijo H., Shioda S., and Sasaki S.: Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinoma. J Oral Pathol Med 18: 391–395, 1989.
9. Yokoi T., Yamaguchi A., Odajima T., and Furukawa K.: Establishment and characterization of a human cell line derived from a squamous cell carcinoma of the tongue. Tumor Res 23: 43–57, 1988.
10. Yokoi T., Hirata S., Nishimura F., Miyakawa A., Odajima T., Kohama G., and Mochizuki Y. : Some properties of a newly established human cell line derived from an oral squamous cell carcinoma. Tumor Res 25: 93–103, 1990.
11. Boukamp P., Petrussevka R. T., Breitkreutz D., Hornung J., Markham A., and Fusenig N.E.: Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761–771, 1988.
12. Albini A., Iwamoto Y., Kleinman H. K., Martin G. R., Aaronson S. A., Kozlowski J.M., and McEwan R.N.: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239–3245, 1987.
13. Kim C.H.: The greater chemotactic network for lymphcyte trafficking: chemokines and beyond. Curre Opin Hematol 12: 298–304, 2005.
14. Kleinhans M., Tun-Kyi A., Gilliet M., Kadin M. E., Dummer R., Burg G., and Nestle F.O.: Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma. Blood 101: 1487–1493, 2003.
15. Ishida T., Utsunomiya A., Iida S., Inagaki H., Takatsuka Y., Kusumoto S., Shimizu S., Ito M., Komatsu H., Wakita A., Eimoto T., Matsushima K., and Ueda R.: Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res 9: 3625–3634, 2003.
16. Muller A., Homy B., Sato H., Niamfrng G., Catron D., Buchanan M., McClannahan T., Murphy E., Yuan W., Wagner S. N., Barrera J. L., Mohar A., Verástegui E., and Zlotnik A.: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50–56, 2001.
17. Mashino K., Sadanaga N., Yamaguchi H., Tanaka F., Ohta M., Shibuta K., Inoue H., and Mori M.: Expression of chemokine receptor CCR7 is associated with lymph node metatsasis of gastric carcinoma. Cancer Res 63: 2937–2941, 2002.
18. Ou D. L., Chen C. L., Lin S. B., Hsu C.H., and Lin L.I.: Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy. J Pathol 210: 363–373, 2006.
19. Ding Y., Shimada Y., Maeda M., Kawabe A., Kaganoi J., Komoto I., Hashimoto Y., Miyake M., Hashida H., and Imamura M.: Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res 9: 3406–3412, 2003.
20. Wang J., Xi L., Hunt J. L., Coodling W., Whiteside T. L., Chen Z., Godfrey T.E., and Ferris R.L.: Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of head and neck identifies a novel metastatic phenotype. Cancer Res 64: 1861–1866, 2004.
21. Günther K., Leier J., Henning G., Dimmler A., WeiySbach R., Hohenberger W., and Förster R.: Prediction of lymph node metastasis in cololectal carcinoma by expression of chemokine receptor CCR7. Int J Cancer 116: 726–733, 2005.
22. Tsuzuki, H., Takahashi N., Kojima A., Narita N., Sunaga H., Takabayashi T., and Fujieda S.: Oral and oropharyngeal squamous cell carcinomas expressing CCR7 have poor prognoses. Auris Nasus Larynx 33: 37–42, 2006.
23. Hasegawa H., Nomura T., Kohno M., Tateishi N., Suzuki Y., Maeda N., Fujisawa R., Yoshie O., and Fujita S.: Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid prgans adalt T-cell leukemia cells. Boold 95: 330–338, 2000.
24. Li A., Varney M.L., and Singh R.K.: Expression of interleukin 8 and its receptors in human colon carcinoma cells with differnt metastatic potentials. Clin Cancer Res 7: 3298–3304, 2001.
25. Watanabe H., Iwase M., Ohashi M., and Nagumo M.: Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines. Oral Oncol 38: 670–679, 2002.
26. Morgan A. J., Guillen C., Symon F. A., Huynh T. T., Berry M. A., Entwisle J. J., Briskin M., Pavorf I.D., and Wardlaw A.J.: Expression of CXCR6 and its ligand CXCL1 in the lung in health and disease. Clin Exp Allergy 35: 1572–1580, 2005.
27. Heydtmann M., Lalor P. F., Eksteen J. A., Hubscher S. G., Briskin M., and Adams D.H.: CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphcytes to cholangiocytes and hepatocytes within the inflamed human liver. J Immunol 174: 1055–1062, 2005.
28. Hara T., Katakai T., Lee J. H., Nambu Y., Nakajima-Nagata N., Gonda H., Sugai M., and Shimizu A.: A transmembrane chemokine, CXC chemokine ligand 16, expressed by lymph node fibroblastic reticular cells has the potential to regulate T cell migration and adhesion. Int Immunol 18: 301–311, 2006.
29. Shulby S. A., Dolloff N. G., Stearns M. E., Meucci O., and Fatatis A.: CX3CR1-Fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells. Cancer Res 64: 4693–4698, 2004.
30. Yoneda O., Imai T., Inoue H., Nishimura M., Minami Y., Bloom E. T., Mimori T., Domae N., and Umehara H.: Membrane-bound form of fratalkine induces IFN-y production by NK cells: a role for Th1 response. Eur J Immunol 33: 53–58, 2003.
31. Uchida D., Begum N. M., Almofti A., Nakashiro K., Kawamata H., Tateishi Y., Hamakawa H., Yoshida H., and Sato M.,: Possible role of stromal-cell-derived factor-1/ CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. Exp Cell Res 290: 289–302, 2003.
32. Yoshida T., Imai T., Kakizaki M., Nishimura M., Takagi S., and Yoshie O.: Identification of single C motif-1/lymphotactin receptor XCR1. J Biol Chem 273: 16551–16554, 1998.
33. Huang H., Li F., Cairns CM., Gordon J.R., and Xiang J.: Neutrophils and B cells express XCR1 receptor and che-motactically respond to lymphotactin. Biochem Biophys Res Commun 281: 378–382, 2001.
34. Sallusto F., Lening D., Mackay C.R., and Lanzavecchia A.: Flexible programs of chemokine receptor expression on human palarized T helper 1 and 2 lymphocytes. J Exp Med 187: 875–883, 1998.
35. Massague J.: Receptors for the TGF-β family. Cell 69: 1067–1070, 1992.
36. Okumura K., Konishi A., Tanaka M., Hagino T., Nagayasu H., Katoh M., Kawano H., Shibata T., and Kanazawa M.: Autocrine action of transforming growth factor-β1 (TGF-β1) in the invasiveness of human oral squamous cell carcinoma cell lines. Jpn J Oral Maxillofac Surg 42 : 962–968, 1996.
37. Santibáñez J.F., Guerrero J., Quintanilla M., Fabra A., and Martínez J.: Transforming growth factor-β1 modulates matrix metalloproteinase-9 production through the Ras/MAPK signaling pathway in transformed keratinocytes. Biochem Biophys Res Commun 296: 267–273, 2002.
38. Chan T. O., Rittenhouse S.E., and Tsichilis P.N.: AKT/PKB and other D3 phosphainositide-regulated kinases; kinase activation by phosphoinositide-dependent phospholylation. Ann Rev Biochem 68: 965–1014, 1999.
39. Roux P.P., and Blenis J.: ERK and p 38 MApk-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68: 320–344, 2004.